Hercules Capital Inc (HTGC) Actualités

Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.

Facility significantly increases future financial and operational flexibilityUp to $200M available, with $30...

Form 8-K - Current report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Hercules Capital Reports Third Quarter 2024 Financial Results

Record Q3 2024 Total Investment Income of $125.2 Million, an Increase of 7.3% Year-over-Year Q3 2024 Net Investment Income “NII” of $83.2...

Hercules Capital Declares a Total Cash Distribution of $0.48 per Share for the Third Quarter 2024

The Total Cash Distribution of $0.48 per Share for the Third Quarter 2024 is Comprised of a $0.40 per Share Base Distribution and an $0.08 per...

Hercules Capital Announces Date for Release of Third Quarter 2024 Financial Results and Conference Call

Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Hercules Capital Receives Reaffirmed Baa3 Investment Grade Rating with Revised Outlook to Positive from Moody’s Investors Service

Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to innovative venture...

Form 4 - Statement of changes in beneficial ownership of securities